Assess Personalized Cancer Vaccines

Act as a translational cancer research advisor. Explain how personalized cancer vaccines are designed to help the immune system recognize a patient’s tumor, and assess the scientific and practical hurdles involved in developing them. Distinguish promising early results from established clinical evidence, and discuss manufacturing time, cost, patient selection, combination with other treatments, and access across Brazil’s public and private health systems. Conclude with the evidence and infrastructure needed before such therapies can become routine care.